TY  - GEN
AU  - Brown,Lindsay A
AU  - Johnson,Karynn
AU  - Leung,Samuel
AU  - Bismar,Tarek A
AU  - Benítez,Javier
AU  - Foulkes,William D
AU  - Huntsman,David G
TI  - Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers
SN  - 1573-7217
PY  - 2010///0820
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclin D1
KW  - Female
KW  - Gene Amplification
KW  - Genes, BRCA1
KW  - Genes, BRCA2
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Proteins
KW  - Nuclear Proteins
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Receptors, Estrogen
KW  - biosynthesis
KW  - Repressor Proteins
KW  - Selective Estrogen Receptor Modulators
KW  - therapeutic use
KW  - Survival Analysis
KW  - Tamoxifen
KW  - Tissue Array Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10549-009-0479-x
ER  -